FRISC
Completed
2,500 enrolled
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Phase 1 Completed
62 enrolled 17 charts
Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
Phase 3 Completed
40 enrolled
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
Phase 2 Completed
27 enrolled 10 charts
IMPLICATION
Completed
167 enrolled
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
Phase 3 Completed
161 enrolled
GenCInibs-Suni
Completed
43 enrolled
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
Completed
20 enrolled
AYAConnect
Phase NA Completed
63 enrolled
CALM: Managing Distress in Malignant Brain Cancer
Phase NA Completed
60 enrolled
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
Completed
149 enrolled
RSR-1
Phase NA Completed
13 enrolled
EARN
Phase NA Completed
33 enrolled
PRIORITY
Completed
346 enrolled 9 charts
P-NeLoP
Phase NA Completed
280 enrolled
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
Phase 1/2 Completed
23 enrolled
SLM + Axitinib for Clear Cell RCC
Phase 1 Completed
46 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
Nephrogreen
Phase NA Completed
12 enrolled
CRYO-BO-2021
Completed
955 enrolled
Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American
Completed
211 enrolled
HERO
Phase NA Completed
113 enrolled
CP-Renal
Completed
16 enrolled
Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue
Phase 1/2 Completed
60 enrolled
REMEDY
Completed
146 enrolled
Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)
Phase 2 Completed
39 enrolled 6 charts
SPIRIT
Phase 2 Completed
121 enrolled 12 charts
Rib Removal and Pain in Partial Nephrectomy
Completed
50 enrolled
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
Completed
72,408 enrolled
IRMK01
Phase NA Completed
387 enrolled
Novel Prognostic Markers in Renal Cancer
Completed
182 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
BANN
Completed
40 enrolled
Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
Phase 1 Completed
29 enrolled
Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab
Phase 2 Completed
26 enrolled
LiVHOU
Completed
178 enrolled
Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging
Phase 2 Completed
25 enrolled 28 charts
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
Completed
15 enrolled
ASPIRE
Phase NA Completed
340 enrolled
Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
Phase 1/2 Completed
15 enrolled 10 charts
Ask Questions (ASQ):Implementation of a Communication Intervention
Phase NA Completed
81 enrolled
Mind-Body Health in Uro-Oncology: Research Study
Phase NA Completed
120 enrolled
Gag-layer in the Urothelium of the Human Upper Urinary Tract
Completed
16 enrolled
Off Clamp Randomization
Phase NA Completed
80 enrolled 18 charts
Assessment of Complications in Patients Who Underwent LPN According to the CCI
Completed
62 enrolled
Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study
Completed
300 enrolled
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Phase 1/2 Completed
58 enrolled 24 charts
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250
Phase 1 Completed
18 enrolled 15 charts
Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.
Phase 1 Completed
26 enrolled 11 charts
The Association of Marital Status With Kidney Cancer Surgery Morbidity
Completed
106,752 enrolled